2539 A phase II trial of AEZS-108 in castration and taxane resistant prostate cancer. (September 2015) - Pinski, J.; Schally, A.V.; Groshen, S.; Denice, T.W.; Liu, S.V.; Quinn, D.; Dorff, T.; Athreya, K.; Yu, S.; Xiong, S.